BioSpace News Archive

Quanta Dialysis Technologies Ltd announced today the formation of a North American Medical Advisory Board (MAB).

Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB: ACOGF)(“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announced that the Company will participate in H.C. Wainwright 23rd Annual Global Investment Conference.

Statera BioPharma, a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, provided an update on the integration of the ImQuest BioSciences business unit and the status of the post-merger stock conversion process.

Anika Therapeutics, Inc., a global joint preservation company focused on early intervention orthopedics, will debut their full joint preservation and restoration product portfolio at the 2021 American Academy of Orthopedic Surgeons Annual Meeting in San Diego, California September 1-3.

The conference will be held virtually on September 13-15, 2021. Greg McKee, Chairman and CEO of Tryp, will provide an overview of the business and its pipeline including Tryp’s Psilocybin-For-Neuropsychiatric Disorders (PFNTM) program for chronic pain and other indications.

NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, and Bionano Genomics, based in San Diego, California, have entered into a procurement and collaboration agreement.

Desert Harvest, a manufacturer of nutritional supplements formulated with a proprietary super-concentrated aloe vera extract, is seeking approval from the U.S. Food and Drug Administration (FDA) for use of its Super-Strength Aloe Vera Capsules in the treatment of interstitial cystitis (IC), the painful chronic bladder condition that affects as many as 12 million men and women.

ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will participate in 1-on-1 meetings with institutional investors at the Goldman Sachs Eleventh Annual Biotech Symposium on September 7, 2021.

Pillar Biosciences today announced the appointment of Randy Pritchard as Chief Executive Officer.

Endosound, Inc. announced today that its EndoSound Vision System received a Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).